Comparison of ALK and LTK structure and sequence. (A) Schematic of

Frontiers ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers

Structural basis for ligand reception by anaplastic lymphoma kinase. - Abstract - Europe PMC

Frontiers Current status and challenges of immunotherapy in ALK rearranged NSCLC

Cell Signaling by Receptor Tyrosine Kinases: Cell

Cancers, Free Full-Text

Mechanism for the activation of the anaplastic lymphoma kinase receptor

Gary W. Reuther's research works Moffitt Cancer Center, Florida and other places

Frontiers Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer